|
US10323236B2
(en)
|
2011-07-22 |
2019-06-18 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
WO2013035099A1
(en)
|
2011-09-08 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
EP3115457B1
(en)
|
2014-03-05 |
2019-10-02 |
National University Corporation Kobe University |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
|
US11390921B2
(en)
|
2014-04-01 |
2022-07-19 |
Adaptive Biotechnologies Corporation |
Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
|
|
CA2946312A1
(en)
|
2014-04-23 |
2015-10-29 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
US10077453B2
(en)
|
2014-07-30 |
2018-09-18 |
President And Fellows Of Harvard College |
CAS9 proteins including ligand-dependent inteins
|
|
US20170335331A1
(en)
|
2014-10-31 |
2017-11-23 |
The Trustees Of The University Of Pennsylvania |
Altering Gene Expression in CART Cells and Uses Thereof
|
|
CA2969619A1
(en)
|
2014-12-03 |
2016-06-09 |
Agilent Technologies, Inc. |
Guide rna with chemical modifications
|
|
KR102763121B1
(ko)
|
2015-02-06 |
2025-02-04 |
내셔널 유니버시티 오브 싱가포르 |
치료적 면역 세포의 효능의 향상 방법
|
|
AU2016243583B2
(en)
*
|
2015-03-27 |
2022-03-10 |
President And Fellows Of Harvard College |
Modified T cells and methods of making and using the same
|
|
KR102888521B1
(ko)
|
2015-04-06 |
2025-11-19 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna
|
|
CN107921148A
(zh)
|
2015-05-08 |
2018-04-17 |
哈佛学院校长同事会 |
通用供体干细胞和相关方法
|
|
EP3322424B1
(en)
|
2015-07-16 |
2023-10-11 |
Yeda Research and Development Co., Ltd. |
Use of anti third party central memory t cells
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
JP6816133B2
(ja)
|
2015-10-05 |
2021-01-20 |
プレシジョン バイオサイエンシズ，インク． |
改変ヒトｔ細胞受容体アルファ定常領域遺伝子を含む遺伝子改変細胞
|
|
EP3359660B1
(en)
|
2015-10-05 |
2019-12-04 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
|
|
IL310721B2
(en)
|
2015-10-23 |
2025-11-01 |
Harvard College |
Nucleobase editors and uses thereof
|
|
JP6923205B2
(ja)
|
2015-11-27 |
2021-08-18 |
国立大学法人神戸大学 |
標的化したｄｎａ配列の核酸塩基を特異的に変換する、単子葉植物のゲノム配列の変換方法、及びそれに用いる分子複合体
|
|
EP4212547A1
(en)
|
2015-12-03 |
2023-07-19 |
Juno Therapeutics, Inc. |
Modified chimeric receptors and related compositions and methods
|
|
WO2017093969A1
(en)
|
2015-12-04 |
2017-06-08 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
ES2970865T3
(es)
|
2015-12-16 |
2024-05-31 |
Gritstone Bio Inc |
Identificación, fabricación y uso de neoantígenos
|
|
WO2017192536A1
(en)
|
2016-05-02 |
2017-11-09 |
University Of Kansas |
Eliminating mhc restriction from the t cell receptor as a strategy for immunotherapy
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
KR20190039115A
(ko)
*
|
2016-07-05 |
2019-04-10 |
더 존스 홉킨스 유니버시티 |
암을 치료하기 위한 crispr/cas9-기반 조성물 및 방법
|
|
CA3029860A1
(en)
*
|
2016-07-05 |
2018-01-11 |
The Johns Hopkins University |
Compositions and methods comprising improvements of crispr guide rnas using the h1 promoter
|
|
CN106191062B
(zh)
*
|
2016-07-18 |
2019-06-14 |
广东华南疫苗股份有限公司 |
一种tcr-/pd-1-双阴性t细胞及其构建方法
|
|
KR102546839B1
(ko)
|
2016-08-03 |
2023-06-23 |
워싱턴 유니버시티 |
키메라 항원 수용체를 이용한 t 세포 악성종양의 치료를 위한 car-t 세포의 유전자 편집
|
|
CN110214183A
(zh)
|
2016-08-03 |
2019-09-06 |
哈佛大学的校长及成员们 |
腺苷核碱基编辑器及其用途
|
|
WO2018031683A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
|
BR112019002779A2
(pt)
|
2016-08-12 |
2019-05-14 |
Toolgen Incorporated |
elemento imunorregulador manipulado e imunidade alterada por este
|
|
IL308824A
(en)
*
|
2016-08-17 |
2024-01-01 |
Factor Bioscience Inc |
Nucleic acid products and methods of administration thereof
|
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
CN106399375A
(zh)
*
|
2016-08-31 |
2017-02-15 |
南京凯地生物科技有限公司 |
利用CRISPR/Cas9敲除人PD‑1基因构建靶向CD19CAR‑T细胞的方法
|
|
CN106480097A
(zh)
*
|
2016-10-13 |
2017-03-08 |
南京凯地生物科技有限公司 |
利用CRISPR/Cas9技术敲除人PD‑1基因构建可靶向MSLN新型CAR‑T细胞的方法及其应用
|
|
MX2019003768A
(es)
*
|
2016-10-03 |
2019-06-24 |
Juno Therapeutics Inc |
Moleculas de enlace especificas de hpv.
|
|
KR102622411B1
(ko)
|
2016-10-14 |
2024-01-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
CN110520530A
(zh)
|
2016-10-18 |
2019-11-29 |
明尼苏达大学董事会 |
肿瘤浸润性淋巴细胞和治疗方法
|
|
AU2017347854B2
(en)
*
|
2016-10-27 |
2022-12-08 |
Intima Bioscience, Inc. |
Viral methods of T cell therapy
|
|
NZ753794A
(en)
*
|
2016-11-07 |
2023-05-26 |
Genovie Ab |
An engineered multi-component system for identification and characterisation of t-cell receptors, t-cell antigens and their functional interaction
|
|
DK4039800T5
(da)
|
2016-11-07 |
2024-07-29 |
Genovie Ab |
Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellreceptorer og t-cellantigener
|
|
JP6803480B2
(ja)
|
2016-11-07 |
2020-12-23 |
ジェノヴィー エービーＧｅｎｏｖｉｅ Ａｂ |
Ｔ細胞受容体の合成及びｔｃｒ提示細胞への安定なゲノム組込みのための二部分装置
|
|
GB201622044D0
(en)
*
|
2016-12-22 |
2017-02-08 |
Ucl Business Plc |
T cell-targeted T cells
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
WO2018132508A1
(en)
*
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
Methods and compositions relating to ex vivo culture and modulation of t cells
|
|
WO2018132479A1
(en)
*
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
Modified t cells and methods of their use
|
|
ES3064681T3
(en)
*
|
2017-01-18 |
2026-04-28 |
Yeda Res And Development Co Ltd |
Genetically modified veto cells and use of same in immunotherapy
|
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
|
US12390514B2
(en)
|
2017-03-09 |
2025-08-19 |
President And Fellows Of Harvard College |
Cancer vaccine
|
|
US11542496B2
(en)
|
2017-03-10 |
2023-01-03 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
MX2019010906A
(es)
*
|
2017-03-14 |
2020-02-12 |
Juno Therapeutics Inc |
Metodos para almacenamiento criogenico.
|
|
WO2018175636A2
(en)
*
|
2017-03-22 |
2018-09-27 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
KR20240116572A
(ko)
|
2017-03-23 |
2024-07-29 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
|
|
WO2018191490A1
(en)
*
|
2017-04-13 |
2018-10-18 |
The Trustees Of The University Of Pennsylvania |
Use of gene editing to generate universal tcr re-directed t cells for adoptive immunotherapy
|
|
CN110785489A
(zh)
*
|
2017-05-04 |
2020-02-11 |
宾夕法尼亚大学董事会 |
使用CRISPR/Cpf1在T细胞中进行基因编辑的组合物和方法
|
|
EP4029943A1
(en)
*
|
2017-05-08 |
2022-07-20 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
|
JP7235391B2
(ja)
|
2017-05-08 |
2023-03-08 |
ツールゲン インコーポレイテッド |
人工的に操作された免疫細胞
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
MX2019013514A
(es)
|
2017-05-12 |
2020-01-20 |
Crispr Therapeutics Ag |
Materiales y metodos para modificar celulas por ingenieria genetica y usos de los mismos en inmunooncologia.
|
|
CN110944652A
(zh)
*
|
2017-06-12 |
2020-03-31 |
爱莫里大学 |
T细胞抗原靶向的嵌合抗原受体(car)以及在细胞疗法中的用途
|
|
WO2018232356A1
(en)
|
2017-06-15 |
2018-12-20 |
The Regents Of The University Of California |
Targeted non-viral dna insertions
|
|
CN109963944A
(zh)
*
|
2017-06-20 |
2019-07-02 |
江苏恒瑞医药股份有限公司 |
体外敲除T细胞中靶基因的方法以及该方法中使用的crRNA
|
|
WO2018236909A1
(en)
*
|
2017-06-20 |
2018-12-27 |
La Jolla Institute For Allergy And Immunology |
Engineered t-cell receptors and methods of their use in modulating inflammatory responses and treating atherosclerosis
|
|
EP3645021A4
(en)
|
2017-06-30 |
2021-04-21 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
|
EP3645038B1
(en)
|
2017-06-30 |
2026-02-18 |
Precision Biosciences, Inc. |
Genetically-modified t cells comprising a modified intron in the t cell receptor alpha gene
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
US20190038733A1
(en)
|
2017-08-10 |
2019-02-07 |
National University Of Singapore |
T cell receptor-deficient chimeric antigen receptor t-cells and methods of use thereof
|
|
EP3441461A1
(en)
*
|
2017-08-11 |
2019-02-13 |
Baylor College of Medicine |
Cd1d-restricted nkt cells as a platform for off-the-shelf cancer immunotherapy
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
CN109456943A
(zh)
*
|
2017-09-06 |
2019-03-12 |
亘喜生物科技（上海）有限公司 |
通用型嵌合抗原受体t细胞制备技术
|
|
US20200261502A1
(en)
*
|
2017-09-08 |
2020-08-20 |
Carsgen Therapeutics Co., Ltd. |
Genetically engineered t cell and application thereof
|
|
EP3686275A4
(en)
*
|
2017-09-18 |
2021-09-29 |
Edigene Inc. |
GENE EDITING LYMPHOCYTE T AND RELATED USE
|
|
KR20260026092A
(ko)
|
2017-09-19 |
2026-02-25 |
메사추세츠 인스티튜트 오브 테크놀로지 |
키메라 항원 수용체 t 세포 요법을 위한 조성물 및 그의 용도
|
|
CN109517820B
(zh)
|
2017-09-20 |
2021-09-24 |
北京宇繁生物科技有限公司 |
一种靶向HPK1的gRNA以及HPK1基因编辑方法
|
|
CN107630006B
(zh)
*
|
2017-09-30 |
2020-09-11 |
山东兴瑞生物科技有限公司 |
一种制备tcr与hla双基因敲除的t细胞的方法
|
|
JP2020537515A
(ja)
|
2017-10-03 |
2020-12-24 |
ジュノー セラピューティクス インコーポレイテッド |
Ｈｐｖ特異的結合分子
|
|
EP4576103A3
(en)
|
2017-10-10 |
2025-08-27 |
Gritstone bio, Inc. |
Neoantigen identification using hotspots
|
|
EP3702454A4
(en)
|
2017-10-10 |
2021-08-04 |
Hiroshima University |
METHOD FOR GENERATING ANTIGEN-SPECIFIC REGULATORY T-CELLS (TREG) WITH EFFECTOR T-CELL (TEFF) ANTIGEN RECEPTORS
|
|
JP7207661B2
(ja)
*
|
2017-10-10 |
2023-01-18 |
国立大学法人広島大学 |
Ｐｌａｔｉｎｕｍ ＴＡＬＥＮを用いたＴ細胞受容体の完全置換技術
|
|
KR20250107288A
(ko)
|
2017-10-16 |
2025-07-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
CN107759699A
(zh)
*
|
2017-10-18 |
2018-03-06 |
银丰生物工程集团有限公司 |
靶向cd30抗原的转基因t细胞及其制备方法与应用
|
|
CN107759700A
(zh)
*
|
2017-10-18 |
2018-03-06 |
银丰生物工程集团有限公司 |
靶向cd19抗原的转基因t细胞及其制备方法与应用
|
|
CN107827989A
(zh)
*
|
2017-10-18 |
2018-03-23 |
银丰生物工程集团有限公司 |
靶向骨髓瘤bcma抗原的转基因t细胞及其制备方法与应用
|
|
CN107723275B
(zh)
*
|
2017-10-20 |
2020-09-04 |
重庆精准生物技术有限公司 |
通用型car-t细胞及其制备方法和应用
|
|
JP7101419B2
(ja)
*
|
2017-10-27 |
2022-07-15 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
内因性ｔ細胞受容体の標的置換
|
|
SG11202004026QA
(en)
|
2017-10-30 |
2020-05-28 |
Pact Pharma Inc |
Primary cell gene editing
|
|
CN107916269B
(zh)
*
|
2017-11-17 |
2020-12-11 |
山东兴瑞生物科技有限公司 |
靶向cd19的tcr基因、制备方法、具有该基因的质粒、试剂盒及应用
|
|
CN111630602A
(zh)
|
2017-11-22 |
2020-09-04 |
磨石肿瘤生物技术公司 |
减少新抗原的接合表位呈递
|
|
WO2019106163A1
(en)
*
|
2017-12-01 |
2019-06-06 |
Cellectis |
Reprogramming of genetically engineered primary immune cells
|
|
EP3724326A1
(en)
*
|
2017-12-11 |
2020-10-21 |
Editas Medicine, Inc. |
Cpf1-related methods and compositions for gene editing
|
|
US11738047B2
(en)
|
2017-12-12 |
2023-08-29 |
The Trustees Of The University Of Pennsylvania |
Genetically modified immune cells targeting NY-ESO-1 and methods of use thereof
|
|
CA3082204A1
(en)
*
|
2017-12-13 |
2019-06-20 |
Janssen Biotech, Inc. |
Immortalized car-t cells genetically modified to eliminate t-cell receptor and beta 2-microglobulin expression
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
EP3684399A1
(en)
*
|
2017-12-29 |
2020-07-29 |
Cellectis |
Method for improving production of car t cells
|
|
US12247060B2
(en)
|
2018-01-09 |
2025-03-11 |
Marengo Therapeutics, Inc. |
Calreticulin binding constructs and engineered T cells for the treatment of diseases
|
|
CN108559760A
(zh)
*
|
2018-01-09 |
2018-09-21 |
陕西师范大学 |
基于CRISPR靶向基因组修饰技术建立荧光素酶knock-in细胞系的方法
|
|
EP3737765B2
(en)
|
2018-01-12 |
2025-01-22 |
Curocell Inc. |
Enhanced immune cells using dual shrna and composition including the same
|
|
WO2019143961A2
(en)
*
|
2018-01-19 |
2019-07-25 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting gamma delta t cells with chimeric antigen receptors
|
|
CN108103027B
(zh)
*
|
2018-02-02 |
2021-12-24 |
中国医学科学院血液病医院（血液学研究所） |
高效率血细胞重编程同时实现基因编辑的方法
|
|
WO2019157454A1
(en)
*
|
2018-02-11 |
2019-08-15 |
Memorial Sloan-Kettering Cancer Center |
Non-hla restricted t cell receptors and uses thereof
|
|
EP3759131A4
(en)
|
2018-02-27 |
2021-12-01 |
Gritstone bio, Inc. |
NEOANTIGEN IDENTIFICATION WITH PAN ALLELE MODELS
|
|
MX2020009272A
(es)
|
2018-03-06 |
2021-01-08 |
Univ Pennsylvania |
Receptores de antígeno quimérico del antígeno de membrana específico de próstata y métodos de uso de los mismos.
|
|
US11447769B2
(en)
|
2018-03-27 |
2022-09-20 |
The Trustees Of The University Of Pennsylvania |
Modified immune cells having enhanced function and methods for screening for same
|
|
US11649455B2
(en)
|
2018-03-30 |
2023-05-16 |
University Of Geneva |
Micro RNA expression constructs and uses thereof
|
|
IL277722B2
(en)
|
2018-04-02 |
2025-12-01 |
Pact Pharma Inc |
Peptide-mhc compacts
|
|
CA3094468A1
(en)
|
2018-04-05 |
2019-10-10 |
Juno Therapeutics, Inc. |
Methods of producing cells expressing a recombinant receptor and related compositions
|
|
EP3773908A1
(en)
*
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
T cell receptors and engineered cells expressing same
|
|
MA52207A
(fr)
|
2018-04-05 |
2021-02-17 |
Editas Medicine Inc |
Lymphocytes t exprimant un récepteur recombinant, polynucléotides et procédés associés
|
|
US11786554B2
(en)
|
2018-04-12 |
2023-10-17 |
Precision Biosciences, Inc. |
Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene
|
|
CN108490174B
(zh)
*
|
2018-04-18 |
2022-06-24 |
上海尚珞生物医药科技有限公司 |
检测car-t细胞的方法及其应用
|
|
CN120442670A
(zh)
*
|
2018-04-26 |
2025-08-08 |
贝勒医学院 |
用于选择性靶向活化的致病性t细胞和nk细胞的自体/同种异体免疫防御受体
|
|
MX2020012028A
(es)
|
2018-05-11 |
2021-03-29 |
Crispr Therapeutics Ag |
Metodos y composiciones para tratar el cancer.
|
|
KR20210045360A
(ko)
|
2018-05-16 |
2021-04-26 |
신테고 코포레이션 |
가이드 rna 설계 및 사용을 위한 방법 및 시스템
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
JP2021525518A
(ja)
*
|
2018-05-31 |
2021-09-27 |
ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ |
細胞をゲノム編集及び活性化するための方法
|
|
EP3802798A4
(en)
*
|
2018-05-31 |
2022-05-11 |
Washington University |
CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T) FOR TREATMENT OF CANCER
|
|
CN110616188B
(zh)
*
|
2018-06-20 |
2023-05-09 |
上海隆耀生物科技有限公司 |
一种通用型car-t细胞及其制备方法和应用
|
|
CA3105448A1
(en)
|
2018-07-03 |
2020-01-09 |
Elstar Therapeutics, Inc. |
Anti-tcr antibody molecules and uses thereof
|
|
US12522807B2
(en)
|
2018-07-09 |
2026-01-13 |
The Broad Institute, Inc. |
RNA programmable epigenetic RNA modifiers and uses thereof
|
|
WO2020033366A1
(en)
*
|
2018-08-08 |
2020-02-13 |
Nantbio, Inc. |
Recombinant cd1-restricted t cells and methods
|
|
CN110904045A
(zh)
*
|
2018-09-17 |
2020-03-24 |
中国科学院动物研究所 |
经修饰的t细胞、其制备方法及用途
|
|
CN112805371B
(zh)
*
|
2018-09-21 |
2025-10-31 |
克莱格医学有限公司 |
基于CRISPR/Cas系统对细胞进行基因编辑的方法
|
|
JP7250031B2
(ja)
*
|
2018-09-25 |
2023-03-31 |
公益財団法人微生物化学研究会 |
新規ウイルスベクターおよびその製造方法と使用方法
|
|
AU2019346335B2
(en)
|
2018-09-28 |
2024-07-25 |
Massachusetts Institute Of Technology |
Collagen-localized immunomodulatory molecules and methods thereof
|
|
CN109295106B
(zh)
*
|
2018-09-30 |
2020-07-24 |
北京鼎成肽源生物技术有限公司 |
一种hafft1细胞
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
CN113227374A
(zh)
*
|
2018-10-16 |
2021-08-06 |
因特利亚治疗公司 |
用于免疫疗法的组合物和方法
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
BR112021008041A2
(pt)
*
|
2018-11-07 |
2021-08-10 |
Crispr Therapeutics Ag |
terapia contra o câncer com células imunitárias anti-cd33
|
|
WO2020095249A1
(en)
|
2018-11-07 |
2020-05-14 |
Crispr Therapeutics Ag |
Anti-liv1 immune cell cancer therapy
|
|
CA3118830A1
(en)
|
2018-11-07 |
2020-05-14 |
Crispr Therapeutics Ag |
Anti-ptk7 immune cell cancer therapy
|
|
WO2020103013A1
(en)
*
|
2018-11-21 |
2020-05-28 |
Nanjing Bioheng Biotech Co., Ltd |
Modified t cells and uses thereof
|
|
AU2019397033B2
(en)
|
2018-12-12 |
2023-06-29 |
Kite Pharma, Inc. |
Chimeric antigen receptors and CAR-T cells and methods of use
|
|
CN109652378B
(zh)
*
|
2018-12-29 |
2020-04-24 |
广州百暨基因科技有限公司 |
一种功能增强的通用型car-t细胞及其制备方法和用途
|
|
CN109722437B
(zh)
*
|
2018-12-29 |
2020-01-07 |
广州百暨基因科技有限公司 |
一种通用型car-t细胞及其制备方法和用途
|
|
EP3911735A4
(en)
*
|
2019-01-16 |
2023-07-12 |
Beam Therapeutics, Inc. |
MODIFIED IMMUNE CELLS WITH INCREASED ANTINEOPLASTIC ACTIVITY AND RESISTANCE TO IMMUNOSUPPRESSION
|
|
CN113557036A
(zh)
|
2019-01-18 |
2021-10-26 |
奥泽生物疗法公司 |
基因编辑以改善关节功能
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
IL285534B2
(en)
|
2019-02-12 |
2025-04-01 |
Pact Pharma Inc |
Preparations and methods for identifying antigen-specific T cells
|
|
CN120174005A
(zh)
|
2019-02-13 |
2025-06-20 |
比姆医疗股份有限公司 |
具有用于修饰靶标序列中核碱基的腺苷脱氨酶碱基编辑器的经修饰的免疫细胞
|
|
CN119039441A
(zh)
|
2019-02-21 |
2024-11-29 |
马伦戈治疗公司 |
与nkp30结合的抗体分子及其用途
|
|
GB2599228B
(en)
|
2019-02-21 |
2024-02-07 |
Marengo Therapeutics Inc |
Multifunctional molecules that bind to T cell related cancer cells and uses thereof
|
|
CA3130825A1
(en)
|
2019-02-22 |
2020-08-27 |
Garvan Institute Of Medical Research |
Methods of modulating immune response via snvs of a20 that can "tune" the immune system of a subject
|
|
CN109913501B
(zh)
*
|
2019-03-01 |
2022-08-16 |
华东师范大学 |
一种靶向cd152的复制缺陷性重组慢病毒car-t转基因载体及构建方法
|
|
CN111676195A
(zh)
*
|
2019-03-11 |
2020-09-18 |
北京卡替医疗技术有限公司 |
一种治疗t细胞肿瘤的ucar免疫细胞
|
|
CN113906140B
(zh)
*
|
2019-03-18 |
2025-01-28 |
路德维格癌症研究院 |
A2/ny-eso-1特异性t细胞受体及其用途
|
|
WO2020191233A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020191378A1
(en)
|
2019-03-21 |
2020-09-24 |
Allogene Therapeutics, Inc. |
METHODS FOR ENHANCING TCRαβ+ CELL DEPLETION EFFICIENCY
|
|
KR102691932B1
(ko)
|
2019-04-03 |
2024-08-06 |
프리시젼 바이오사이언시스 인코포레이티드 |
마이크로RNA-적응 shRNA(shRNAmiR)를 포함하는 유전자-변형 면역 세포
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
MX2021013359A
(es)
*
|
2019-04-30 |
2022-01-31 |
Crispr Therapeutics Ag |
Terapia de celulas alogénicas de neoplasias malignas de células b usando células t modificadas genéticamente dirigidas a cd19.
|
|
WO2020263399A1
(en)
|
2019-06-26 |
2020-12-30 |
Massachusetts Institute Of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
CN112430575B
(zh)
*
|
2019-08-26 |
2024-01-19 |
深圳市菲鹏生物治疗股份有限公司 |
通用型car-t细胞及其制备方法、应用以及抗肿瘤药物
|
|
KR20220051401A
(ko)
*
|
2019-09-06 |
2022-04-26 |
크리스퍼 테라퓨틱스 아게 |
배양 중 개선된 지속성을 갖는 유전적으로 조작된 t 세포
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
EP4034138A4
(en)
*
|
2019-09-27 |
2024-07-31 |
Beam Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIQUID CANCERS
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
CN114929862A
(zh)
*
|
2019-11-13 |
2022-08-19 |
克里斯珀医疗股份公司 |
用于制备表达嵌合抗原受体的t细胞的生产方法
|
|
KR20220097985A
(ko)
*
|
2019-11-13 |
2022-07-08 |
크리스퍼 테라퓨틱스 아게 |
Car-t 세포의 제조 방법
|
|
AU2020388690A1
(en)
*
|
2019-11-20 |
2022-06-09 |
Cartherics Pty. Ltd. |
Method for providing immune cells with enhanced function
|
|
US20210155924A1
(en)
*
|
2019-11-27 |
2021-05-27 |
Stitch Bio, Llc |
Methods and compositions for inducing tumor cell death
|
|
AU2020418199B2
(en)
*
|
2020-01-02 |
2024-06-13 |
Ningbo T-Maximum Biopharmaceuticals Co., Ltd. |
Modified immune effector cell and preparation method therefor
|
|
AU2020416273A1
(en)
|
2020-01-03 |
2022-07-28 |
Marengo Therapeutics, Inc. |
Anti-TCR antibody molecules and uses thereof
|
|
WO2021147891A1
(zh)
*
|
2020-01-21 |
2021-07-29 |
苏州克睿基因生物科技有限公司 |
一种经修饰的免疫效应细胞及其用途
|
|
US20210254005A1
(en)
*
|
2020-01-23 |
2021-08-19 |
Kangstem Biotech Co., Ltd. |
Off-the-shelf stem cell and immune cell, and a pharmaceutical composition including the same
|
|
CA3174332A1
(en)
|
2020-04-21 |
2021-10-28 |
Jason PERERA |
Tcr/bcr profiling
|
|
US12433954B2
(en)
|
2020-05-01 |
2025-10-07 |
Massachusetts Institute Of Technology |
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
|
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
IL297761A
(en)
|
2020-05-08 |
2022-12-01 |
Broad Inst Inc |
Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
|
|
CN113684258B
(zh)
*
|
2020-05-18 |
2024-08-20 |
上海赛比曼生物科技有限公司 |
用于检测鼠源tcr转基因拷贝数的试剂盒及方法
|
|
CA3188143A1
(en)
*
|
2020-06-25 |
2021-12-30 |
The Methodist Hospital |
Antigen-specific t cell receptors and chimeric antigen receptors, and methods of use in immune signaling modulation for cancer immunotherapy
|
|
JP2023531531A
(ja)
|
2020-06-26 |
2023-07-24 |
ジュノ セラピューティクス ゲーエムベーハー |
組換え受容体を条件付きで発現する操作されたｔ細胞、関連ポリヌクレオチド、および方法
|
|
WO2022012531A1
(zh)
*
|
2020-07-14 |
2022-01-20 |
苏州克睿基因生物科技有限公司 |
一种经修饰的免疫细胞的制备方法
|
|
US20230248768A1
(en)
*
|
2020-07-15 |
2023-08-10 |
Nanjing Bioheng Biotech Co., Ltd |
Engineered immune cell for allotransplantation
|
|
EP4182461A4
(en)
*
|
2020-07-16 |
2025-03-19 |
Orthobio Therapeutics, Inc. |
GENE EDITING TO IMPROVE JOINT FUNCTION
|
|
IL300500A
(en)
*
|
2020-08-20 |
2023-04-01 |
A2 Biotherapeutics Inc |
Preparations and methods for the treatment of mesothelin positive cancer
|
|
CA3196831A1
(en)
|
2020-09-25 |
2022-03-31 |
Beam Therapeutics Inc. |
Fratricide resistant modified immune cells and methods of using the same
|
|
JP2023546067A
(ja)
*
|
2020-10-13 |
2023-11-01 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
ｍＲＮＡ治療剤のためのＴ細胞のインビボ標的化
|
|
CN112266899A
(zh)
*
|
2020-10-26 |
2021-01-26 |
北京卡替医疗技术有限公司 |
修饰的免疫细胞及其用途
|
|
WO2022106731A1
(en)
*
|
2020-11-23 |
2022-05-27 |
Ludwig-Maximilians-Universität München |
Cd28-targeting chimeric antigen receptor (car) t cells, methods of generation and uses thereof
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
KR20230118887A
(ko)
|
2020-12-03 |
2023-08-14 |
센츄리 쎄라퓨틱스 인코포레이티드 |
유전자 조작 세포 및 이의 용도
|
|
WO2022144632A1
(en)
|
2020-12-30 |
2022-07-07 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into nk cells
|
|
CN112899227B
(zh)
*
|
2021-01-14 |
2022-09-13 |
中国科学院微生物研究所 |
一种调控辅助性t细胞功能的方法
|
|
CN117693508A
(zh)
|
2021-03-03 |
2024-03-12 |
朱诺治疗学股份有限公司 |
T细胞疗法和dgk抑制剂的组合
|
|
US12577290B2
(en)
|
2021-03-04 |
2026-03-17 |
Allogene Therapeutics, Inc. |
FasL expression and FasR gene knockout to protect therapeutic cells from allogeneic rejection and activation-induced cell death
|
|
JP2024512368A
(ja)
*
|
2021-03-08 |
2024-03-19 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Ｔ細胞機能障害を評価および治療するための組成物および方法
|
|
JP2024534945A
(ja)
|
2021-09-10 |
2024-09-26 |
アジレント・テクノロジーズ・インク |
化学修飾を有するプライム編集のためのガイドｒｎａ
|
|
US20240390493A1
(en)
*
|
2021-09-29 |
2024-11-28 |
The Johns Hopkins University |
Methods and compositions to augment efficacy and reduce toxicity of non-engrafting, cd8-depleted allogenic donor lymphocyte infusions
|
|
WO2023057285A1
(en)
|
2021-10-06 |
2023-04-13 |
Miltenyi Biotec B.V. & Co. KG |
Method for targeted gene insertion into immune cells
|
|
JP2024537991A
(ja)
|
2021-10-14 |
2024-10-18 |
アーセナル バイオサイエンシズ インコーポレイテッド |
共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞
|
|
US20260083848A1
(en)
|
2021-11-03 |
2026-03-26 |
Viracta Therapeutics, Inc. |
Combination of car t-cell therapy with btk inhibitors and methods of use thereof
|
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
|
CN113980907B
(zh)
*
|
2021-12-24 |
2022-03-15 |
山东兴瑞生物科技有限公司 |
一种抗flt3嵌合抗原受体修饰的t细胞及其在制备治疗aml药物中的应用
|
|
CN114591963B
(zh)
*
|
2022-05-10 |
2022-07-19 |
上海优替济生生物医药有限公司 |
sgRNA及利用其构建GM-CSF(-)细胞的方法
|
|
EP4583876A1
(en)
|
2022-09-08 |
2025-07-16 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|
|
US20260085331A1
(en)
*
|
2022-09-19 |
2026-03-26 |
Emendobio Inc. |
Biallelic Knockout of PDCD1
|
|
WO2024100604A1
(en)
|
2022-11-09 |
2024-05-16 |
Juno Therapeutics Gmbh |
Methods for manufacturing engineered immune cells
|
|
EP4630567A2
(en)
*
|
2022-12-09 |
2025-10-15 |
Research Institute at Nationwide Children's Hospital |
Chimeric antigen receptor (car) t cells and uses thereof
|
|
WO2024121426A1
(en)
*
|
2022-12-09 |
2024-06-13 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Method for optimizing t cells for immuno-therapy
|
|
JP2026504491A
(ja)
|
2023-02-03 |
2026-02-05 |
ツェー３エス２ ゲーエムベーハー |
操作された免疫細胞の非ウイルス的製造のための方法
|
|
KR20250166108A
(ko)
*
|
2023-02-10 |
2025-11-27 |
난징 바이오흐엥 바이오테크 씨오., 엘티디 |
기능이 향상된 세포 치료법
|
|
IL322949A
(en)
|
2023-03-03 |
2025-10-01 |
Arsenal Biosciences Inc |
Systems targeting PSMA and CA9
|
|
WO2025082418A1
(zh)
*
|
2023-10-18 |
2025-04-24 |
苏州沙砾生物科技有限公司 |
一种鉴定靶标的方法及其应用
|
|
WO2026025092A1
(en)
|
2024-07-26 |
2026-01-29 |
Juno Therapeutics, Inc. |
Synthetic promoters for t cell expression
|